Richard Klausner, Director at Juno Therapeutics, Inc. (JUNO), sold 12,000 shares at $49.48 ($594K) on 2015-11-13, disclosed to the SEC on 2015-11-13.
Scheduled sale ($594k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.48 | 11,500 | $569K | 95.8% |
| 2 | $50.18 | 500 | $25K | 4.2% |
| Total | $49.51 avg | 12,000 | $594K | 100% |
| Filing → |
| LYEL | SELL | 2022-09-27 | $71K | — | Filing → |
| JUNO | SELL | 2018-01-09 | $1.2M | — | Filing → |
| JUNO | SELL | 2017-12-22 | $3.2M | — | Filing → |